1834 Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-180
| Closed | -$44K | – | 206 |
|
|
2022
Q2 | $44K | Buy |
+180
| New | +$44.1K | 0.01% | 278 |
|
|
2022
Q1 | – | Sell |
-200
| Closed | -$45K | – | 440 |
|
|
2021
Q4 | $45K | Buy |
200
+14
| +8% | +$2.96K | 0.01% | 265 |
|
|
2021
Q3 | $40K | Hold |
186
| – | – | ﹤0.01% | 280 |
|
|
2021
Q2 | $45K | Hold |
186
| – | – | 0.01% | 278 |
|
|
2021
Q1 | $46K | Hold |
186
| – | – | 0.01% | 271 |
|
|
2020
Q4 | $43K | Buy |
186
+6
| +3% | +$1.38K | 0.01% | 273 |
|
|
2020
Q3 | $46K | Hold |
180
| – | – | 0.01% | 266 |
|
|
2020
Q2 | $42K | Hold |
180
| – | – | 0.01% | 251 |
|
|
2020
Q1 | $36K | Hold |
180
| – | – | 0.01% | 267 |
|
|
2019
Q4 | $43K | Hold |
180
| – | – | 0.01% | 285 |
|
|
2019
Q3 | $35K | Sell |
180
-400
| -69% | -$76.8K | 0.01% | 295 |
|
|
2019
Q2 | $107K | Sell |
580
-200
| -26% | -$35.8K | 0.02% | 231 |
|
|
2019
Q1 | $148K | Hold |
780
| – | – | 0.02% | 211 |
|
|
2018
Q4 | $152K | Buy |
780
+600
| +333% | +$117K | 0.03% | 201 |
|
|
2018
Q3 | $37K | Hold |
180
| – | – | 0.01% | 295 |
|
|
2018
Q2 | $33K | Hold |
180
| – | – | 0.01% | 300 |
|
|
2018
Q1 | $31K | Sell |
180
-760
| -81% | -$140K | 0.01% | 310 |
|
|
2017
Q4 | $163K | Buy |
+940
| New | +$166K | 0.03% | 197 |
|
|
2017
Q3 | – | Sell |
-26,391
| Closed | -$4.54M | – | 172 |
|
|
2017
Q2 | $4.54M | Sell |
26,391
-11,777
| -31% | -$1.92M | 0.86% | 47 |
|
|
2017
Q1 | $6.26M | Sell |
38,168
-852
| -2% | -$142K | 1.2% | 31 |
|
|
2016
Q4 | $5.71M | Buy |
39,020
+3,913
| +11% | +$589K | 1.15% | 33 |
|
|
2016
Q3 | $5.86M | Buy |
35,107
+642
| +2% | +$109K | 1.27% | 31 |
|
|
2016
Q2 | $5.24M | Buy |
34,465
+691
| +2% | +$107K | 1.14% | 32 |
|
|
2016
Q1 | $5.06M | Buy |
33,774
+2,640
| +8% | +$392K | 1.16% | 32 |
|
|
2015
Q4 | $5.05M | Buy |
31,134
+1,538
| +5% | +$242K | 1.19% | 30 |
|
|
2015
Q3 | $4.09M | Buy |
29,596
+22,277
| +304% | +$3.51M | 1.02% | 35 |
|
|
2015
Q2 | $1.12M | Buy |
7,319
+31
| +0.4% | +$4.97K | 0.31% | 77 |
|
|
2015
Q1 | $1.17M | Buy |
7,288
+380
| +6% | +$59.8K | 0.32% | 78 |
|
|
2014
Q4 | $1.1M | Sell |
6,908
-16,572
| -71% | -$2.58M | 0.3% | 76 |
|
|
2014
Q3 | $3.3M | Sell |
23,480
-3,581
| -13% | -$468K | 0.91% | 41 |
|
|
2014
Q2 | $3.2M | Buy |
27,061
+1,950
| +8% | +$226K | 0.87% | 42 |
|
|
2014
Q1 | $3.1M | Buy |
25,111
+19,389
| +339% | +$2.35M | 0.91% | 44 |
|
|
2013
Q4 | $653K | Buy |
5,722
+1,532
| +37% | +$174K | 0.19% | 98 |
|
|
2013
Q3 | $469K | Sell |
4,190
-350
| -8% | -$38K | 0.15% | 101 |
|
|
2013
Q2 | $448K | Buy |
+4,540
| New | +$471K | 0.15% | 104 |
|
Other funds holding AMGN
1834 Investment Advisors's AMGN Position: Q3 2022 in Review
1834 Investment Advisors sold out of Amgen (AMGN) in Q3 2022, closing a stake of 180 shares — an estimated $44K sold.
1834 Investment Advisors first reported a position in AMGN in Q2 2013 and held it in 35 quarters. The position peaked at $6.26M in Q1 2017. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- 1834 Investment Advisors reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
- 1834 Investment Advisors sold 180 Amgen shares in Q3 2022, an estimated $44K.
- 1834 Investment Advisors first reported a position in Amgen in Q2 2013 and held it in 35 quarters.
- 1834 Investment Advisors's Amgen position peaked at $6.26M in Q1 2017.
- 2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on 1834 Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.